Ganga Pharmaceuticals Share Price
Small Cap | Pharmaceuticals and health care | BSE: 539680
₹11.69 
-1.96 (-14.36 %)
Last Updated: 21 Feb 2025 12:00 AM
BEARISH
Overview
Open (₹) 11.13
High (₹) 11.85
Low (₹) 10.92
Prev. Close (₹) 13.65
Volume 64,000
VWAP (₹) 11.17
ROCE (%) 3.32
Industry P/E 43.77
TTM P/E 106.27
P/B Ratio 0.80
Market Cap (₹) Cr.5.65
Dividend Yield (%)--
EPS (₹) 0.07
ROE0.48%
Sales Growth (%) 5.78
Profit Growth (%)18.6
Day Range
11.8511.85
52 Week Range
10.9227.10
Historical Returns
Returns (6M)
-40.27 %
Returns (1Y)
-52.11 %
Returns (3Y)
-2.01 %
Returns (5Y)
65.82 %
Returns (6M)
-40.27 %
Returns (1Y)
-52.11 %
Returns (3Y)
-2.01 %
Returns (5Y)
65.82 %
SWOT Analysis
Technicals
Technical Rating
BEARISHRSI 48.25
MFI 18.92
ATR 2.64
Commodity Channel Index -138.57
ROC125 N/A
ROC21 -50.26
Williams %R -92.84
Resistance & Support
| Type | Resistance 1 | Resistance 2 | Resistance 3 | PP | Support 1 | Support 2 | Support 3 |
|---|---|---|---|---|---|---|---|
| Current | 12.06 | 12.42 | 12.99 | 11.49 | 11.13 | 10.56 | 10.20 |
| Week Ago | 17.00 | 17.00 | 17.00 | 17.00 | 17.00 | 17.00 | 17.00 |
EMA & SMA
11.69
Current Price
Bullish Moving Averages
0
Bearish Moving Averages
18
5 Day 15.58
9 Day 15.78
10 Day 15.91
12 Day 16.93
14 Day 17.50
20 Day 19.89
26 Day 20.87
50 Day 19.11
100 Day 15.37
200 Day N/A
Deals & Announcements
Bulk and Block Deals
| Client Name | Deal Type | Action | Date | Avg. Price | Quantity | Exchange |
|---|---|---|---|---|---|---|
| PANKAJ KESHAV TORNE | bulk | Sell | 21 Feb, 2025 | ₹10.98 | 48,000 | BSE |
| ANJU AGARWAL | bulk | Sell | 24 Aug, 2023 | ₹10.70 | 40,000 | BSE |
| PANKAJ KESHAV TORNE | bulk | Buy | 24 Aug, 2023 | ₹10.70 | 40,000 | BSE |
| NIRANJAN KUMAR GOEL | bulk | Buy | 15 Feb, 2022 | ₹15.37 | 32,000 | BSE |
| NIRANJAN KUMAR GOEL | bulk | Buy | 14 Feb, 2022 | ₹16.05 | 24,000 | BSE |
| BABALBHAI MANILAL PATEL | bulk | Sell | 28 Jan, 2022 | ₹11.01 | 24,000 | BSE |
| BABALBHAI MANILAL PATEL | bulk | Sell | 25 Jan, 2022 | ₹11.42 | 24,000 | BSE |
| MUNEESH KAPOOR | bulk | Buy | 25 Jan, 2022 | ₹11.42 | 24,000 | BSE |
| ARYAMAN BROKING LIMITED | bulk | Sell | 16 Mar, 2020 | ₹7.05 | 56,000 | BSE |
| SHWETA AKASH SHARMA | bulk | Buy | 16 Mar, 2020 | ₹7.05 | 32,000 | BSE |
Insider Trading
Corporate Actions
No corporate actions available.
Announcements
| Date | Source | Detail |
|---|---|---|
| 08 Jan, 2025 | BSE India | Certificate in terms of Regulation 74(5) of the SEBI (DP) Regulations, 2018 for the quarter ended December 31, 2024 |
| 08 Nov, 2024 | BSE India | Statement of Deviation for September 30, 2024 |
| 08 Nov, 2024 | BSE India | Un-audited financial results for the half year ended on September 30, 2024 |
| 08 Nov, 2024 | BSE India | Approved the Un-audited financial results of the Company for the half year ended on September 30, 2024. |
| 06 Nov, 2024 | BSE India | Board Meeting intimation for consider and approve the Un-audited Financial Results of the Company for the half year ended on September 30, 2024 |
| 05 Nov, 2024 | BSE India | Ganga Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2024 ,inter alia, to consider and approve The Un-Audited Financial Results Of The Company For The Half Year Ended On September 30,2024 |
| 09 Oct, 2024 | BSE India | Certificate under Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2024 |
| 25 Sept, 2024 | BSE India | Proceeding and Voting Results of the 35th Annual General Meeting (\AGM\) of Ganga Pharmaceuticals Limited held on Wednesday, September 25,2024 along with the Scrutinizer Report |
| 25 Sept, 2024 | BSE India | Proceeding and Voting Results of the 35th Annual General Meeting (\AGM\) of Ganga Pharmaceuticals Limited (''the Company\) held on Wednesday, September 25, 2024 |
Board Meetings
| Purpose | Details | Meeting Date | Broadcast Date |
|---|---|---|---|
| Half Yearly Results | -- | 06 Nov, 2024 | 08 Nov, 2024 |
| Audited Results | -- | 07 May, 2024 | 16 May, 2024 |
| Preferential issue of shares | -- | 29 Nov, 2023 | 04 Dec, 2023 |
| Half Yearly Results | -- | 31 Oct, 2023 | 08 Nov, 2023 |
| Audited Results | -- | 09 May, 2023 | 18 May, 2023 |
| Half Yearly Results | -- | 31 Oct, 2022 | 11 Nov, 2022 |
| Audited Results | -- | 12 May, 2022 | 25 May, 2022 |
| Half Yearly Results | -- | 02 Nov, 2021 | 09 Nov, 2021 |
| Audited Results | -- | 18 Jun, 2021 | 28 Jun, 2021 |
| Half Yearly Results | -- | 28 Oct, 2020 | 05 Nov, 2020 |
Share Holding Pattern
| Owner Name | Sept, 2024 | Mar, 2024 | Jan, 2024 | Sept, 2023 |
|---|
About Ganga Pharmaceuticals
Ganga Pharmaceuticals is a Public Limited Listed company incorporated on 11/09/1989 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L99999MH1989PLC053392 and registration number is 053392. Currently company belongs to the Industry of Pharmaceuticals. Company’s Total Operating Revenue is Rs. 2.74 Cr. and Equity Capital is Rs. 4.84 Cr. for the Year ended 31/03/2024. Read More
Parent Organisation
Not Applicable
Founded
1989
Managing Director
Mr. Bharat Brijmohan Sharma
NSE Symbol
--
Ganga Pharmaceuticals Management
| Name | Designation |
|---|---|
| Mr. Sanjay Vyankatesh Kulkarni | Chairman & Non-Exe.Director |
| Mr. Bharat Brijmohan Sharma | Managing Director & CEO |
| Mrs. Srijna Bharat Sharma | Whole Time Director |
| Mr. Sachin Chandrakant Chavan | Independent Director |
| Mr. Chetan Bhikhubhai Patel | Independent Director |
Peer Comparison
| Stocks | Market Cap | Market Price | 52 Week Low-High |
|---|---|---|---|
| SunPhrmInds | ₹4,46,576.22 | ₹1,613.60  ₹1,639.50(-1.58%) | ₹1,249.800 - ₹1,960.200 |
| Divis Labora | ₹1,56,123.40 | ₹5,726.40  ₹5,702.55(0.42%) | ₹3,350.050 - ₹6,448.750 |
| Cipla | ₹1,21,675.13 | ₹1,463.35 ₹1,476.75(-0.91%) | ₹1,240.700 - ₹1,702.000 |
| ManKind Phar | ₹1,18,478.90 | ₹2,342.10 ₹2,298.80(1.88%) | ₹1,910.100 - ₹3,050.000 |
| DrReddysLab | ₹1,15,939.04 | ₹1,128.15 ₹1,164.55(-3.13%) | ₹1,104.690 - ₹1,420.200 |
FAQs on Ganga Pharmaceuticals
What is the share price of Ganga Pharmaceuticals?
The share price of Ganga Pharmaceuticals on 21 Feb, 2025 is ₹ 11.69.
What is 52W high and 52W low share price of Ganga Pharmaceuticals?
The highest and lowest 52W share prices of Ganga Pharmaceuticals are ₹ 28.490 and ₹ 15.000
What is the market cap of Ganga Pharmaceuticals?
The market capitalization of Ganga Pharmaceuticals as of 21 Feb, 2025 is ₹ 5.65 Crores
What is the P/E ratio of Ganga Pharmaceuticals?
The current P/E ratio of Ganga Pharmaceuticals as of 21 Feb, 2025 is 43.77
What is the PB ratio of Ganga Pharmaceuticals?
The PB ratio of Ganga Pharmaceuticals as of 21 Feb, 2025 is 0.80
Top Gainers
948IHFL26I
IBHFL NCD186
₹845.00
₹705.00 (0.20%)
GREAVESCOT
Greaves
₹281.85
₹234.90 (0.20%)
ASHSI
Ashirwd Stl
₹45.66
₹38.05 (0.20%)
CAPRO
Caprola.Chem
₹62.40
₹52.00 (0.20%)
Top Losers
DHANBANK
Dhanalak.Bnk
₹32.19
₹35.97 (-0.11%)
08MPD
08MPD
₹8.66
₹9.62 (-0.10%)
BALTE
BalurghtTran
₹27.13
₹31.24 (-0.13%)
DARSHANORNA
Darshan Orna
₹4.57
₹5.07 (-0.10%)
Market Indices
Sensex
₹78,699.07
₹78,472.48 (0.00%)